Blood pressure management is important for reducing the risk of kidney disease and CVD in type 1 diabetes, with 2023 ADA guidelines recommending a target goal of 3 mg/mmol at baseline, SGLT2i resulted in a reduction in UACR of as much as 30% over 52 weeks follow-up [37,38,39]
Call Aetna, review your plans formulary, or use Ros insurance checker to see if your plan covers Mounjaro (which has the same active ingredient as Zepbound but is approved for type 2 diabetes), other weight loss GLP-1s like Saxenda or Wegovy, or prescription weight loss pills
Can I switch from GLP-1 injections to pills
Beltre, people tend to get headaches from Wegovy during the first few weeks of treatment
Crosstalk between the redox signalling and the detoxification: GSTs under redox control
Tuy nhin, ty tng tnh trng v c a ca mi ngi s c mt liu trnh khc nhau